vs
Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $22.7M, roughly 1.2× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -79.3%, a 80.0% gap on every dollar of revenue. On growth, Beta Bionics, Inc. posted the faster year-over-year revenue change (56.6% vs 22.9%).
Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
BBNX vs RFIL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $22.7M |
| Net Profit | $-21.9M | $173.0K |
| Gross Margin | 59.5% | 36.8% |
| Operating Margin | -47.4% | 4.0% |
| Net Margin | -79.3% | 0.8% |
| Revenue YoY | 56.6% | 22.9% |
| Net Profit YoY | 23.6% | 172.7% |
| EPS (diluted) | $-0.49 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $22.7M | ||
| Q3 25 | $27.3M | $19.8M | ||
| Q2 25 | $23.2M | $18.9M | ||
| Q1 25 | $17.6M | $19.2M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $16.8M | ||
| Q2 24 | — | $16.1M |
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $173.0K | ||
| Q3 25 | $-14.2M | $392.0K | ||
| Q2 25 | $-16.9M | $-245.0K | ||
| Q1 25 | $-28.7M | $-245.0K | ||
| Q4 24 | — | $-238.0K | ||
| Q3 24 | — | $-705.0K | ||
| Q2 24 | — | $-4.3M |
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | 36.8% | ||
| Q3 25 | 55.5% | 34.0% | ||
| Q2 25 | 53.8% | 31.5% | ||
| Q1 25 | 50.9% | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% |
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | 4.0% | ||
| Q3 25 | -62.5% | 3.6% | ||
| Q2 25 | -85.5% | 0.6% | ||
| Q1 25 | -105.7% | 0.3% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | -2.5% | ||
| Q2 24 | — | -2.6% |
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | 0.8% | ||
| Q3 25 | -52.1% | 2.0% | ||
| Q2 25 | -72.6% | -1.3% | ||
| Q1 25 | -162.5% | -1.3% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | — | -4.2% | ||
| Q2 24 | — | -26.7% |
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $0.01 | ||
| Q3 25 | $-0.33 | $0.04 | ||
| Q2 25 | $-0.39 | $-0.02 | ||
| Q1 25 | $-0.93 | $-0.02 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $199.5M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $271.2M | $35.2M |
| Total Assets | $304.4M | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $5.1M | ||
| Q3 25 | $228.7M | $3.0M | ||
| Q2 25 | $249.7M | $3.6M | ||
| Q1 25 | $231.5M | $1.3M | ||
| Q4 24 | — | $839.0K | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $1.4M |
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $35.2M | ||
| Q3 25 | $294.8M | $34.8M | ||
| Q2 25 | $301.6M | $34.2M | ||
| Q1 25 | $313.8M | $34.2M | ||
| Q4 24 | — | $34.1M | ||
| Q3 24 | — | $34.1M | ||
| Q2 24 | — | $34.6M |
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $73.0M | ||
| Q3 25 | $330.0M | $73.2M | ||
| Q2 25 | $330.0M | $72.7M | ||
| Q1 25 | $338.0M | $70.4M | ||
| Q4 24 | — | $71.0M | ||
| Q3 24 | — | $71.9M | ||
| Q2 24 | — | $72.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.1M |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 9.0% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $2.1M | ||
| Q3 25 | $-8.7M | $-311.0K | ||
| Q2 25 | $-13.6M | $2.2M | ||
| Q1 25 | $-20.0M | $601.0K | ||
| Q4 24 | — | $-244.0K | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $197.0K |
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $2.0M | ||
| Q3 25 | $-10.0M | $-419.0K | ||
| Q2 25 | $-15.4M | $2.2M | ||
| Q1 25 | $-20.3M | $574.0K | ||
| Q4 24 | — | $-418.0K | ||
| Q3 24 | — | $2.1M | ||
| Q2 24 | — | $28.0K |
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | 9.0% | ||
| Q3 25 | -36.7% | -2.1% | ||
| Q2 25 | -66.2% | 11.4% | ||
| Q1 25 | -115.1% | 3.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 0.2% |
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 0.3% | ||
| Q3 25 | 4.7% | 0.5% | ||
| Q2 25 | 7.7% | 0.2% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBNX
Segment breakdown not available.
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
